Global Giant Cell Arteritis Therapeutic Supply, Demand and Key Producers, 2023-2029
The global Giant Cell Arteritis Therapeutic market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
This report studies the global Giant Cell Arteritis Therapeutic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Giant Cell Arteritis Therapeutic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Giant Cell Arteritis Therapeutic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Giant Cell Arteritis Therapeutic total market, 2018-2029, (USD Million)
Global Giant Cell Arteritis Therapeutic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Giant Cell Arteritis Therapeutic total market, key domestic companies and share, (USD Million)
Global Giant Cell Arteritis Therapeutic revenue by player and market share 2018-2023, (USD Million)
Global Giant Cell Arteritis Therapeutic total market by Type, CAGR, 2018-2029, (USD Million)
Global Giant Cell Arteritis Therapeutic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Giant Cell Arteritis Therapeutic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie, Inc., Bristol-Myers Squibb Company and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Giant Cell Arteritis Therapeutic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Giant Cell Arteritis Therapeutic Market, By Region:
1. How big is the global Giant Cell Arteritis Therapeutic market?
2. What is the demand of the global Giant Cell Arteritis Therapeutic market?
3. What is the year over year growth of the global Giant Cell Arteritis Therapeutic market?
4. What is the total value of the global Giant Cell Arteritis Therapeutic market?
5. Who are the major players in the global Giant Cell Arteritis Therapeutic market?
6. What are the growth factors driving the market demand?
Giant cell arteritis (GCA) is a granulomatous medium and large-vessel vasculitis. It is the most common form of systemic vasculitis, with an incidence of between 15 and 25 cases per 100,000 persons over 50 years of age.
This report studies the global Giant Cell Arteritis Therapeutic demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Giant Cell Arteritis Therapeutic, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Giant Cell Arteritis Therapeutic that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Giant Cell Arteritis Therapeutic total market, 2018-2029, (USD Million)
Global Giant Cell Arteritis Therapeutic total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Giant Cell Arteritis Therapeutic total market, key domestic companies and share, (USD Million)
Global Giant Cell Arteritis Therapeutic revenue by player and market share 2018-2023, (USD Million)
Global Giant Cell Arteritis Therapeutic total market by Type, CAGR, 2018-2029, (USD Million)
Global Giant Cell Arteritis Therapeutic total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Giant Cell Arteritis Therapeutic market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Kiniksa Pharmaceuticals, Ltd., Regeneron, GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., Novartis AG, AbbVie, Inc., Bristol-Myers Squibb Company and Abbott, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Giant Cell Arteritis Therapeutic market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Giant Cell Arteritis Therapeutic Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Prednisone
- Methotrexate
- Tocilizumab
- Aspirin
- Corticosteroids
- Immunosuppressive Agents
- Anticoagulants
- Others
- Sanofi
- Kiniksa Pharmaceuticals, Ltd.
- Regeneron
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd.
- Novartis AG
- AbbVie, Inc.
- Bristol-Myers Squibb Company
- Abbott
- Johnson & Johnson Services, Inc.
- Johns Hopkins Hospital
- Fortis Healthcare
- American College of Rheumatology
- Duke University Health System
- Lahey Clinic Foundation
1. How big is the global Giant Cell Arteritis Therapeutic market?
2. What is the demand of the global Giant Cell Arteritis Therapeutic market?
3. What is the year over year growth of the global Giant Cell Arteritis Therapeutic market?
4. What is the total value of the global Giant Cell Arteritis Therapeutic market?
5. Who are the major players in the global Giant Cell Arteritis Therapeutic market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Giant Cell Arteritis Therapeutic Introduction
1.2 World Giant Cell Arteritis Therapeutic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Giant Cell Arteritis Therapeutic Total Market by Region (by Headquarter Location)
1.3.1 World Giant Cell Arteritis Therapeutic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.3 China Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.4 Europe Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.5 Japan Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.6 South Korea Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.7 ASEAN Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.8 India Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Giant Cell Arteritis Therapeutic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Giant Cell Arteritis Therapeutic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.2 World Giant Cell Arteritis Therapeutic Consumption Value by Region
2.2.1 World Giant Cell Arteritis Therapeutic Consumption Value by Region (2018-2023)
2.2.2 World Giant Cell Arteritis Therapeutic Consumption Value Forecast by Region (2024-2029)
2.3 United States Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.4 China Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.5 Europe Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.6 Japan Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.7 South Korea Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.8 ASEAN Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.9 India Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
3 WORLD GIANT CELL ARTERITIS THERAPEUTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Giant Cell Arteritis Therapeutic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Giant Cell Arteritis Therapeutic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Giant Cell Arteritis Therapeutic in 2022
3.2.3 Global Concentration Ratios (CR8) for Giant Cell Arteritis Therapeutic in 2022
3.3 Giant Cell Arteritis Therapeutic Company Evaluation Quadrant
3.4 Giant Cell Arteritis Therapeutic Market: Overall Company Footprint Analysis
3.4.1 Giant Cell Arteritis Therapeutic Market: Region Footprint
3.4.2 Giant Cell Arteritis Therapeutic Market: Company Product Type Footprint
3.4.3 Giant Cell Arteritis Therapeutic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Giant Cell Arteritis Therapeutic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Giant Cell Arteritis Therapeutic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Giant Cell Arteritis Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Giant Cell Arteritis Therapeutic Consumption Value Comparison
4.2.1 United States VS China: Giant Cell Arteritis Therapeutic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Giant Cell Arteritis Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Giant Cell Arteritis Therapeutic Companies and Market Share, 2018-2023
4.3.1 United States Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023)
4.4 China Based Companies Giant Cell Arteritis Therapeutic Revenue and Market Share, 2018-2023
4.4.1 China Based Giant Cell Arteritis Therapeutic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023)
4.5 Rest of World Based Giant Cell Arteritis Therapeutic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Giant Cell Arteritis Therapeutic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prednisone
5.2.2 Methotrexate
5.2.3 Tocilizumab
5.2.4 Aspirin
5.3 Market Segment by Type
5.3.1 World Giant Cell Arteritis Therapeutic Market Size by Type (2018-2023)
5.3.2 World Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029)
5.3.3 World Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Giant Cell Arteritis Therapeutic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Corticosteroids
6.2.2 Immunosuppressive Agents
6.2.3 Anticoagulants
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Giant Cell Arteritis Therapeutic Market Size by Application (2018-2023)
6.3.2 World Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029)
6.3.3 World Giant Cell Arteritis Therapeutic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Giant Cell Arteritis Therapeutic Product and Services
7.1.4 Sanofi Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Kiniksa Pharmaceuticals, Ltd.
7.2.1 Kiniksa Pharmaceuticals, Ltd. Details
7.2.2 Kiniksa Pharmaceuticals, Ltd. Major Business
7.2.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product and Services
7.2.4 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Kiniksa Pharmaceuticals, Ltd. Recent Developments/Updates
7.2.6 Kiniksa Pharmaceuticals, Ltd. Competitive Strengths & Weaknesses
7.3 Regeneron
7.3.1 Regeneron Details
7.3.2 Regeneron Major Business
7.3.3 Regeneron Giant Cell Arteritis Therapeutic Product and Services
7.3.4 Regeneron Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Regeneron Recent Developments/Updates
7.3.6 Regeneron Competitive Strengths & Weaknesses
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Details
7.4.2 GlaxoSmithKline plc Major Business
7.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product and Services
7.4.4 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 GlaxoSmithKline plc Recent Developments/Updates
7.4.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Details
7.5.2 F. Hoffmann-La Roche Ltd. Major Business
7.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product and Services
7.5.4 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7.5.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Giant Cell Arteritis Therapeutic Product and Services
7.6.4 Novartis AG Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 AbbVie, Inc.
7.7.1 AbbVie, Inc. Details
7.7.2 AbbVie, Inc. Major Business
7.7.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Product and Services
7.7.4 AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AbbVie, Inc. Recent Developments/Updates
7.7.6 AbbVie, Inc. Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Company Major Business
7.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product and Services
7.8.4 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.8.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.9 Abbott
7.9.1 Abbott Details
7.9.2 Abbott Major Business
7.9.3 Abbott Giant Cell Arteritis Therapeutic Product and Services
7.9.4 Abbott Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Abbott Recent Developments/Updates
7.9.6 Abbott Competitive Strengths & Weaknesses
7.10 Johnson & Johnson Services, Inc.
7.10.1 Johnson & Johnson Services, Inc. Details
7.10.2 Johnson & Johnson Services, Inc. Major Business
7.10.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product and Services
7.10.4 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
7.10.6 Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
7.11 Johns Hopkins Hospital
7.11.1 Johns Hopkins Hospital Details
7.11.2 Johns Hopkins Hospital Major Business
7.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product and Services
7.11.4 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Johns Hopkins Hospital Recent Developments/Updates
7.11.6 Johns Hopkins Hospital Competitive Strengths & Weaknesses
7.12 Fortis Healthcare
7.12.1 Fortis Healthcare Details
7.12.2 Fortis Healthcare Major Business
7.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Product and Services
7.12.4 Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Fortis Healthcare Recent Developments/Updates
7.12.6 Fortis Healthcare Competitive Strengths & Weaknesses
7.13 American College of Rheumatology
7.13.1 American College of Rheumatology Details
7.13.2 American College of Rheumatology Major Business
7.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Product and Services
7.13.4 American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 American College of Rheumatology Recent Developments/Updates
7.13.6 American College of Rheumatology Competitive Strengths & Weaknesses
7.14 Duke University Health System
7.14.1 Duke University Health System Details
7.14.2 Duke University Health System Major Business
7.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Product and Services
7.14.4 Duke University Health System Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Duke University Health System Recent Developments/Updates
7.14.6 Duke University Health System Competitive Strengths & Weaknesses
7.15 Lahey Clinic Foundation
7.15.1 Lahey Clinic Foundation Details
7.15.2 Lahey Clinic Foundation Major Business
7.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product and Services
7.15.4 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Lahey Clinic Foundation Recent Developments/Updates
7.15.6 Lahey Clinic Foundation Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Giant Cell Arteritis Therapeutic Industry Chain
8.2 Giant Cell Arteritis Therapeutic Upstream Analysis
8.3 Giant Cell Arteritis Therapeutic Midstream Analysis
8.4 Giant Cell Arteritis Therapeutic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Giant Cell Arteritis Therapeutic Introduction
1.2 World Giant Cell Arteritis Therapeutic Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Giant Cell Arteritis Therapeutic Total Market by Region (by Headquarter Location)
1.3.1 World Giant Cell Arteritis Therapeutic Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.3 China Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.4 Europe Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.5 Japan Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.6 South Korea Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.7 ASEAN Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.3.8 India Giant Cell Arteritis Therapeutic Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Giant Cell Arteritis Therapeutic Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Giant Cell Arteritis Therapeutic Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.2 World Giant Cell Arteritis Therapeutic Consumption Value by Region
2.2.1 World Giant Cell Arteritis Therapeutic Consumption Value by Region (2018-2023)
2.2.2 World Giant Cell Arteritis Therapeutic Consumption Value Forecast by Region (2024-2029)
2.3 United States Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.4 China Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.5 Europe Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.6 Japan Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.7 South Korea Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.8 ASEAN Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
2.9 India Giant Cell Arteritis Therapeutic Consumption Value (2018-2029)
3 WORLD GIANT CELL ARTERITIS THERAPEUTIC COMPANIES COMPETITIVE ANALYSIS
3.1 World Giant Cell Arteritis Therapeutic Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Giant Cell Arteritis Therapeutic Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Giant Cell Arteritis Therapeutic in 2022
3.2.3 Global Concentration Ratios (CR8) for Giant Cell Arteritis Therapeutic in 2022
3.3 Giant Cell Arteritis Therapeutic Company Evaluation Quadrant
3.4 Giant Cell Arteritis Therapeutic Market: Overall Company Footprint Analysis
3.4.1 Giant Cell Arteritis Therapeutic Market: Region Footprint
3.4.2 Giant Cell Arteritis Therapeutic Market: Company Product Type Footprint
3.4.3 Giant Cell Arteritis Therapeutic Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Giant Cell Arteritis Therapeutic Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Giant Cell Arteritis Therapeutic Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Giant Cell Arteritis Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Giant Cell Arteritis Therapeutic Consumption Value Comparison
4.2.1 United States VS China: Giant Cell Arteritis Therapeutic Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Giant Cell Arteritis Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Giant Cell Arteritis Therapeutic Companies and Market Share, 2018-2023
4.3.1 United States Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023)
4.4 China Based Companies Giant Cell Arteritis Therapeutic Revenue and Market Share, 2018-2023
4.4.1 China Based Giant Cell Arteritis Therapeutic Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023)
4.5 Rest of World Based Giant Cell Arteritis Therapeutic Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Giant Cell Arteritis Therapeutic Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Prednisone
5.2.2 Methotrexate
5.2.3 Tocilizumab
5.2.4 Aspirin
5.3 Market Segment by Type
5.3.1 World Giant Cell Arteritis Therapeutic Market Size by Type (2018-2023)
5.3.2 World Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029)
5.3.3 World Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Giant Cell Arteritis Therapeutic Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Corticosteroids
6.2.2 Immunosuppressive Agents
6.2.3 Anticoagulants
6.2.4 Others
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Giant Cell Arteritis Therapeutic Market Size by Application (2018-2023)
6.3.2 World Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029)
6.3.3 World Giant Cell Arteritis Therapeutic Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Giant Cell Arteritis Therapeutic Product and Services
7.1.4 Sanofi Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Kiniksa Pharmaceuticals, Ltd.
7.2.1 Kiniksa Pharmaceuticals, Ltd. Details
7.2.2 Kiniksa Pharmaceuticals, Ltd. Major Business
7.2.3 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product and Services
7.2.4 Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Kiniksa Pharmaceuticals, Ltd. Recent Developments/Updates
7.2.6 Kiniksa Pharmaceuticals, Ltd. Competitive Strengths & Weaknesses
7.3 Regeneron
7.3.1 Regeneron Details
7.3.2 Regeneron Major Business
7.3.3 Regeneron Giant Cell Arteritis Therapeutic Product and Services
7.3.4 Regeneron Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Regeneron Recent Developments/Updates
7.3.6 Regeneron Competitive Strengths & Weaknesses
7.4 GlaxoSmithKline plc
7.4.1 GlaxoSmithKline plc Details
7.4.2 GlaxoSmithKline plc Major Business
7.4.3 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product and Services
7.4.4 GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 GlaxoSmithKline plc Recent Developments/Updates
7.4.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 F. Hoffmann-La Roche Ltd. Details
7.5.2 F. Hoffmann-La Roche Ltd. Major Business
7.5.3 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product and Services
7.5.4 F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
7.5.6 F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
7.6 Novartis AG
7.6.1 Novartis AG Details
7.6.2 Novartis AG Major Business
7.6.3 Novartis AG Giant Cell Arteritis Therapeutic Product and Services
7.6.4 Novartis AG Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Novartis AG Recent Developments/Updates
7.6.6 Novartis AG Competitive Strengths & Weaknesses
7.7 AbbVie, Inc.
7.7.1 AbbVie, Inc. Details
7.7.2 AbbVie, Inc. Major Business
7.7.3 AbbVie, Inc. Giant Cell Arteritis Therapeutic Product and Services
7.7.4 AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AbbVie, Inc. Recent Developments/Updates
7.7.6 AbbVie, Inc. Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Details
7.8.2 Bristol-Myers Squibb Company Major Business
7.8.3 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product and Services
7.8.4 Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Bristol-Myers Squibb Company Recent Developments/Updates
7.8.6 Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
7.9 Abbott
7.9.1 Abbott Details
7.9.2 Abbott Major Business
7.9.3 Abbott Giant Cell Arteritis Therapeutic Product and Services
7.9.4 Abbott Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Abbott Recent Developments/Updates
7.9.6 Abbott Competitive Strengths & Weaknesses
7.10 Johnson & Johnson Services, Inc.
7.10.1 Johnson & Johnson Services, Inc. Details
7.10.2 Johnson & Johnson Services, Inc. Major Business
7.10.3 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product and Services
7.10.4 Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Johnson & Johnson Services, Inc. Recent Developments/Updates
7.10.6 Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
7.11 Johns Hopkins Hospital
7.11.1 Johns Hopkins Hospital Details
7.11.2 Johns Hopkins Hospital Major Business
7.11.3 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product and Services
7.11.4 Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Johns Hopkins Hospital Recent Developments/Updates
7.11.6 Johns Hopkins Hospital Competitive Strengths & Weaknesses
7.12 Fortis Healthcare
7.12.1 Fortis Healthcare Details
7.12.2 Fortis Healthcare Major Business
7.12.3 Fortis Healthcare Giant Cell Arteritis Therapeutic Product and Services
7.12.4 Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Fortis Healthcare Recent Developments/Updates
7.12.6 Fortis Healthcare Competitive Strengths & Weaknesses
7.13 American College of Rheumatology
7.13.1 American College of Rheumatology Details
7.13.2 American College of Rheumatology Major Business
7.13.3 American College of Rheumatology Giant Cell Arteritis Therapeutic Product and Services
7.13.4 American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 American College of Rheumatology Recent Developments/Updates
7.13.6 American College of Rheumatology Competitive Strengths & Weaknesses
7.14 Duke University Health System
7.14.1 Duke University Health System Details
7.14.2 Duke University Health System Major Business
7.14.3 Duke University Health System Giant Cell Arteritis Therapeutic Product and Services
7.14.4 Duke University Health System Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Duke University Health System Recent Developments/Updates
7.14.6 Duke University Health System Competitive Strengths & Weaknesses
7.15 Lahey Clinic Foundation
7.15.1 Lahey Clinic Foundation Details
7.15.2 Lahey Clinic Foundation Major Business
7.15.3 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product and Services
7.15.4 Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Lahey Clinic Foundation Recent Developments/Updates
7.15.6 Lahey Clinic Foundation Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Giant Cell Arteritis Therapeutic Industry Chain
8.2 Giant Cell Arteritis Therapeutic Upstream Analysis
8.3 Giant Cell Arteritis Therapeutic Midstream Analysis
8.4 Giant Cell Arteritis Therapeutic Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Giant Cell Arteritis Therapeutic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Giant Cell Arteritis Therapeutic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Giant Cell Arteritis Therapeutic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Giant Cell Arteritis Therapeutic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Giant Cell Arteritis Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Giant Cell Arteritis Therapeutic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Giant Cell Arteritis Therapeutic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Giant Cell Arteritis Therapeutic Players in 2022
Table 12. World Giant Cell Arteritis Therapeutic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Giant Cell Arteritis Therapeutic Company Evaluation Quadrant
Table 14. Head Office of Key Giant Cell Arteritis Therapeutic Player
Table 15. Giant Cell Arteritis Therapeutic Market: Company Product Type Footprint
Table 16. Giant Cell Arteritis Therapeutic Market: Company Product Application Footprint
Table 17. Giant Cell Arteritis Therapeutic Mergers & Acquisitions Activity
Table 18. United States VS China Giant Cell Arteritis Therapeutic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Giant Cell Arteritis Therapeutic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Giant Cell Arteritis Therapeutic Revenue Market Share (2018-2023)
Table 23. China Based Giant Cell Arteritis Therapeutic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Giant Cell Arteritis Therapeutic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Giant Cell Arteritis Therapeutic Revenue Market Share (2018-2023)
Table 29. World Giant Cell Arteritis Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Giant Cell Arteritis Therapeutic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Giant Cell Arteritis Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Giant Cell Arteritis Therapeutic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029) & (USD Million)
Table 35. Sanofi Basic Information, Area Served and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Giant Cell Arteritis Therapeutic Product and Services
Table 38. Sanofi Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sanofi Recent Developments/Updates
Table 40. Sanofi Competitive Strengths & Weaknesses
Table 41. Kiniksa Pharmaceuticals, Ltd. Basic Information, Area Served and Competitors
Table 42. Kiniksa Pharmaceuticals, Ltd. Major Business
Table 43. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product and Services
Table 44. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Kiniksa Pharmaceuticals, Ltd. Recent Developments/Updates
Table 46. Kiniksa Pharmaceuticals, Ltd. Competitive Strengths & Weaknesses
Table 47. Regeneron Basic Information, Area Served and Competitors
Table 48. Regeneron Major Business
Table 49. Regeneron Giant Cell Arteritis Therapeutic Product and Services
Table 50. Regeneron Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Regeneron Recent Developments/Updates
Table 52. Regeneron Competitive Strengths & Weaknesses
Table 53. GlaxoSmithKline plc Basic Information, Area Served and Competitors
Table 54. GlaxoSmithKline plc Major Business
Table 55. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product and Services
Table 56. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. GlaxoSmithKline plc Recent Developments/Updates
Table 58. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 59. F. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 60. F. Hoffmann-La Roche Ltd. Major Business
Table 61. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product and Services
Table 62. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 64. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 65. Novartis AG Basic Information, Area Served and Competitors
Table 66. Novartis AG Major Business
Table 67. Novartis AG Giant Cell Arteritis Therapeutic Product and Services
Table 68. Novartis AG Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novartis AG Recent Developments/Updates
Table 70. Novartis AG Competitive Strengths & Weaknesses
Table 71. AbbVie, Inc. Basic Information, Area Served and Competitors
Table 72. AbbVie, Inc. Major Business
Table 73. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product and Services
Table 74. AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AbbVie, Inc. Recent Developments/Updates
Table 76. AbbVie, Inc. Competitive Strengths & Weaknesses
Table 77. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
Table 78. Bristol-Myers Squibb Company Major Business
Table 79. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product and Services
Table 80. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bristol-Myers Squibb Company Recent Developments/Updates
Table 82. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 83. Abbott Basic Information, Area Served and Competitors
Table 84. Abbott Major Business
Table 85. Abbott Giant Cell Arteritis Therapeutic Product and Services
Table 86. Abbott Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Abbott Recent Developments/Updates
Table 88. Abbott Competitive Strengths & Weaknesses
Table 89. Johnson & Johnson Services, Inc. Basic Information, Area Served and Competitors
Table 90. Johnson & Johnson Services, Inc. Major Business
Table 91. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product and Services
Table 92. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 94. Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
Table 95. Johns Hopkins Hospital Basic Information, Area Served and Competitors
Table 96. Johns Hopkins Hospital Major Business
Table 97. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product and Services
Table 98. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Johns Hopkins Hospital Recent Developments/Updates
Table 100. Johns Hopkins Hospital Competitive Strengths & Weaknesses
Table 101. Fortis Healthcare Basic Information, Area Served and Competitors
Table 102. Fortis Healthcare Major Business
Table 103. Fortis Healthcare Giant Cell Arteritis Therapeutic Product and Services
Table 104. Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Fortis Healthcare Recent Developments/Updates
Table 106. Fortis Healthcare Competitive Strengths & Weaknesses
Table 107. American College of Rheumatology Basic Information, Area Served and Competitors
Table 108. American College of Rheumatology Major Business
Table 109. American College of Rheumatology Giant Cell Arteritis Therapeutic Product and Services
Table 110. American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. American College of Rheumatology Recent Developments/Updates
Table 112. American College of Rheumatology Competitive Strengths & Weaknesses
Table 113. Duke University Health System Basic Information, Area Served and Competitors
Table 114. Duke University Health System Major Business
Table 115. Duke University Health System Giant Cell Arteritis Therapeutic Product and Services
Table 116. Duke University Health System Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Duke University Health System Recent Developments/Updates
Table 118. Lahey Clinic Foundation Basic Information, Area Served and Competitors
Table 119. Lahey Clinic Foundation Major Business
Table 120. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product and Services
Table 121. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Giant Cell Arteritis Therapeutic Upstream (Raw Materials)
Table 123. Giant Cell Arteritis Therapeutic Typical Customers
Table 1. World Giant Cell Arteritis Therapeutic Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Giant Cell Arteritis Therapeutic Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Giant Cell Arteritis Therapeutic Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Giant Cell Arteritis Therapeutic Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Giant Cell Arteritis Therapeutic Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Giant Cell Arteritis Therapeutic Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Giant Cell Arteritis Therapeutic Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Giant Cell Arteritis Therapeutic Players in 2022
Table 12. World Giant Cell Arteritis Therapeutic Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Giant Cell Arteritis Therapeutic Company Evaluation Quadrant
Table 14. Head Office of Key Giant Cell Arteritis Therapeutic Player
Table 15. Giant Cell Arteritis Therapeutic Market: Company Product Type Footprint
Table 16. Giant Cell Arteritis Therapeutic Market: Company Product Application Footprint
Table 17. Giant Cell Arteritis Therapeutic Mergers & Acquisitions Activity
Table 18. United States VS China Giant Cell Arteritis Therapeutic Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Giant Cell Arteritis Therapeutic Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
Table 21. United States Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Giant Cell Arteritis Therapeutic Revenue Market Share (2018-2023)
Table 23. China Based Giant Cell Arteritis Therapeutic Companies, Headquarters (Province, Country)
Table 24. China Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Giant Cell Arteritis Therapeutic Revenue Market Share (2018-2023)
Table 26. Rest of World Based Giant Cell Arteritis Therapeutic Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Giant Cell Arteritis Therapeutic Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Giant Cell Arteritis Therapeutic Revenue Market Share (2018-2023)
Table 29. World Giant Cell Arteritis Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Giant Cell Arteritis Therapeutic Market Size by Type (2018-2023) & (USD Million)
Table 31. World Giant Cell Arteritis Therapeutic Market Size by Type (2024-2029) & (USD Million)
Table 32. World Giant Cell Arteritis Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Giant Cell Arteritis Therapeutic Market Size by Application (2018-2023) & (USD Million)
Table 34. World Giant Cell Arteritis Therapeutic Market Size by Application (2024-2029) & (USD Million)
Table 35. Sanofi Basic Information, Area Served and Competitors
Table 36. Sanofi Major Business
Table 37. Sanofi Giant Cell Arteritis Therapeutic Product and Services
Table 38. Sanofi Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Sanofi Recent Developments/Updates
Table 40. Sanofi Competitive Strengths & Weaknesses
Table 41. Kiniksa Pharmaceuticals, Ltd. Basic Information, Area Served and Competitors
Table 42. Kiniksa Pharmaceuticals, Ltd. Major Business
Table 43. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Product and Services
Table 44. Kiniksa Pharmaceuticals, Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Kiniksa Pharmaceuticals, Ltd. Recent Developments/Updates
Table 46. Kiniksa Pharmaceuticals, Ltd. Competitive Strengths & Weaknesses
Table 47. Regeneron Basic Information, Area Served and Competitors
Table 48. Regeneron Major Business
Table 49. Regeneron Giant Cell Arteritis Therapeutic Product and Services
Table 50. Regeneron Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Regeneron Recent Developments/Updates
Table 52. Regeneron Competitive Strengths & Weaknesses
Table 53. GlaxoSmithKline plc Basic Information, Area Served and Competitors
Table 54. GlaxoSmithKline plc Major Business
Table 55. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Product and Services
Table 56. GlaxoSmithKline plc Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. GlaxoSmithKline plc Recent Developments/Updates
Table 58. GlaxoSmithKline plc Competitive Strengths & Weaknesses
Table 59. F. Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 60. F. Hoffmann-La Roche Ltd. Major Business
Table 61. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Product and Services
Table 62. F. Hoffmann-La Roche Ltd. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 64. F. Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 65. Novartis AG Basic Information, Area Served and Competitors
Table 66. Novartis AG Major Business
Table 67. Novartis AG Giant Cell Arteritis Therapeutic Product and Services
Table 68. Novartis AG Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Novartis AG Recent Developments/Updates
Table 70. Novartis AG Competitive Strengths & Weaknesses
Table 71. AbbVie, Inc. Basic Information, Area Served and Competitors
Table 72. AbbVie, Inc. Major Business
Table 73. AbbVie, Inc. Giant Cell Arteritis Therapeutic Product and Services
Table 74. AbbVie, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AbbVie, Inc. Recent Developments/Updates
Table 76. AbbVie, Inc. Competitive Strengths & Weaknesses
Table 77. Bristol-Myers Squibb Company Basic Information, Area Served and Competitors
Table 78. Bristol-Myers Squibb Company Major Business
Table 79. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Product and Services
Table 80. Bristol-Myers Squibb Company Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Bristol-Myers Squibb Company Recent Developments/Updates
Table 82. Bristol-Myers Squibb Company Competitive Strengths & Weaknesses
Table 83. Abbott Basic Information, Area Served and Competitors
Table 84. Abbott Major Business
Table 85. Abbott Giant Cell Arteritis Therapeutic Product and Services
Table 86. Abbott Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Abbott Recent Developments/Updates
Table 88. Abbott Competitive Strengths & Weaknesses
Table 89. Johnson & Johnson Services, Inc. Basic Information, Area Served and Competitors
Table 90. Johnson & Johnson Services, Inc. Major Business
Table 91. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Product and Services
Table 92. Johnson & Johnson Services, Inc. Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Johnson & Johnson Services, Inc. Recent Developments/Updates
Table 94. Johnson & Johnson Services, Inc. Competitive Strengths & Weaknesses
Table 95. Johns Hopkins Hospital Basic Information, Area Served and Competitors
Table 96. Johns Hopkins Hospital Major Business
Table 97. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Product and Services
Table 98. Johns Hopkins Hospital Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Johns Hopkins Hospital Recent Developments/Updates
Table 100. Johns Hopkins Hospital Competitive Strengths & Weaknesses
Table 101. Fortis Healthcare Basic Information, Area Served and Competitors
Table 102. Fortis Healthcare Major Business
Table 103. Fortis Healthcare Giant Cell Arteritis Therapeutic Product and Services
Table 104. Fortis Healthcare Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Fortis Healthcare Recent Developments/Updates
Table 106. Fortis Healthcare Competitive Strengths & Weaknesses
Table 107. American College of Rheumatology Basic Information, Area Served and Competitors
Table 108. American College of Rheumatology Major Business
Table 109. American College of Rheumatology Giant Cell Arteritis Therapeutic Product and Services
Table 110. American College of Rheumatology Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. American College of Rheumatology Recent Developments/Updates
Table 112. American College of Rheumatology Competitive Strengths & Weaknesses
Table 113. Duke University Health System Basic Information, Area Served and Competitors
Table 114. Duke University Health System Major Business
Table 115. Duke University Health System Giant Cell Arteritis Therapeutic Product and Services
Table 116. Duke University Health System Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Duke University Health System Recent Developments/Updates
Table 118. Lahey Clinic Foundation Basic Information, Area Served and Competitors
Table 119. Lahey Clinic Foundation Major Business
Table 120. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Product and Services
Table 121. Lahey Clinic Foundation Giant Cell Arteritis Therapeutic Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 122. Global Key Players of Giant Cell Arteritis Therapeutic Upstream (Raw Materials)
Table 123. Giant Cell Arteritis Therapeutic Typical Customers
LIST OF FIGURES
Figure 1. Giant Cell Arteritis Therapeutic Picture
Figure 2. World Giant Cell Arteritis Therapeutic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Giant Cell Arteritis Therapeutic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 13. Giant Cell Arteritis Therapeutic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Giant Cell Arteritis Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Giant Cell Arteritis Therapeutic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Giant Cell Arteritis Therapeutic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Giant Cell Arteritis Therapeutic Markets in 2022
Figure 27. United States VS China: Giant Cell Arteritis Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Giant Cell Arteritis Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Giant Cell Arteritis Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Giant Cell Arteritis Therapeutic Market Size Market Share by Type in 2022
Figure 31. Prednisone
Figure 32. Methotrexate
Figure 33. Tocilizumab
Figure 34. Aspirin
Figure 35. World Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2018-2029)
Figure 36. World Giant Cell Arteritis Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Giant Cell Arteritis Therapeutic Market Size Market Share by Application in 2022
Figure 38. Corticosteroids
Figure 39. Immunosuppressive Agents
Figure 40. Anticoagulants
Figure 41. Others
Figure 42. Giant Cell Arteritis Therapeutic Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Figure 1. Giant Cell Arteritis Therapeutic Picture
Figure 2. World Giant Cell Arteritis Therapeutic Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Giant Cell Arteritis Therapeutic Total Market Size (2018-2029) & (USD Million)
Figure 4. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Giant Cell Arteritis Therapeutic Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Giant Cell Arteritis Therapeutic Revenue (2018-2029) & (USD Million)
Figure 13. Giant Cell Arteritis Therapeutic Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 16. World Giant Cell Arteritis Therapeutic Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 18. China Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 23. India Giant Cell Arteritis Therapeutic Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Giant Cell Arteritis Therapeutic by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Giant Cell Arteritis Therapeutic Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Giant Cell Arteritis Therapeutic Markets in 2022
Figure 27. United States VS China: Giant Cell Arteritis Therapeutic Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Giant Cell Arteritis Therapeutic Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Giant Cell Arteritis Therapeutic Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Giant Cell Arteritis Therapeutic Market Size Market Share by Type in 2022
Figure 31. Prednisone
Figure 32. Methotrexate
Figure 33. Tocilizumab
Figure 34. Aspirin
Figure 35. World Giant Cell Arteritis Therapeutic Market Size Market Share by Type (2018-2029)
Figure 36. World Giant Cell Arteritis Therapeutic Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Giant Cell Arteritis Therapeutic Market Size Market Share by Application in 2022
Figure 38. Corticosteroids
Figure 39. Immunosuppressive Agents
Figure 40. Anticoagulants
Figure 41. Others
Figure 42. Giant Cell Arteritis Therapeutic Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
